BrokerLens

Accretion Pharmaceuticals Limited IPO (ACCPL)

Status
Listed
Security type
SME
Price band
Rs.96 to Rs.101
Final issue price
Rs 101
Issue size
Not disclosed
Bidding opens
14 May 2025
Bidding closes
16 May 2025
Listing date
21 May 2025

Facts are NSE's own public-issue disclosures, refreshed periodically. Not investment advice; BrokerLens does not publish grey market premium (GMP) or recommend any IPO.

Sponsored
Zerodha

Brokerage-free equity & mutual fund investments

Trade with Zerodha's Kite platform and tools.

  • Zero brokerage on equity delivery
  • ₹20 flat for intraday, F&O, currency and commodity*
  • Free direct mutual fund investing
Open account →
*T&C apply. Investment in securities market are subject to market risks; read all related documents carefully before investing. Full disclaimer at zerodha.com/pricing. Member ID NSE (13906), BSE (6498), MCX (46025).
Sponsored
5paisa

Flat ₹20 per order, every segment

Trade stocks, derivatives and more on 5paisa's platform.

  • ₹20 flat for delivery, intraday and F&O
  • Free account opening
  • Listed on NSE and BSE
Open account →
*T&C apply. Investment in securities market are subject to market risks; read all related documents carefully before investing. SEBI Registration: INZ000010231.

Frequently asked questions

What is the price band for the Accretion Pharmaceuticals Limited IPO?

The Accretion Pharmaceuticals Limited IPO price band is Rs.96 to Rs.101 per share.

When does the Accretion Pharmaceuticals Limited IPO open and close?

Bidding opens 14 May 2025 and closes 16 May 2025.

Is the Accretion Pharmaceuticals Limited IPO a mainboard or SME issue?

Accretion Pharmaceuticals Limited is an SME IPO, listing on NSE Emerge.

When did the Accretion Pharmaceuticals Limited IPO list?

Accretion Pharmaceuticals Limited listed on 21 May 2025.

Does this page show the grey market premium (GMP) for Accretion Pharmaceuticals Limited?

No. GMP is an unregulated, off-exchange estimate BrokerLens does not publish - see methodology. This page shows only NSE's own disclosed facts and, once bidding opens, NSE's own published subscription figures.

Is investing in the Accretion Pharmaceuticals Limited IPO recommended by BrokerLens?

No. BrokerLens does not recommend any IPO, stock or broker. This page states public facts only; it is not investment advice.